Glenn Crosby, MD
Neurological Surgery · Memphis, TNNPI 1760445241
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.0%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Curiteva, Inc. at 31.7% of the total. Reporting peaked in 2024 at $6,860 and has fallen 94.4% since, to $384 in 2025.
Across 38 payments — averaging $297.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Curiteva, Inc.$4K
- Providence Medical Technology, Inc.$2K
- Spine Wave, Inc.$2K
- Centinel Spine, LLC$1K
- Degen Medical, Inc.$1K
- Globus Medical$960
- plus $461 from 5 others
What the payments were for
- Consulting fees$3,50031%
- Travel & lodging$5,99453%
- Food & beverage$1,80616%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Curiteva, Inc. | 2 | $3,587 |
| Providence Medical Technology, Inc. | 2 | $2,031 |
| Spine Wave, Inc. | 6 | $1,675 |
| Centinel Spine, LLC | 8 | $1,408 |
| Degen Medical, Inc. | 5 | $1,178 |
| Globus Medical | 10 | $960 |
| Baxter Healthcare | 1 | $125 |
| Implanet America, Inc. | 1 | $120 |
| Nexxt Spine LLC | 1 | $99 |
| Osseus Fusion Systems, LLC | 1 | $97 |
| Arteriocyte Medical Systems, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRODISC L$671
- XLIF$578
- PRODISC C$369
- PRODISC C VIVO$165
- FLOSEAL$125
- EXCEED BIPLANAR EXPANDABLE INTERBODY SYSTEM$122
- MIDLINE II$103
How this compares
$11,300 in reported general payments places this provider in the 65th percentile of 156 neurological surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cyclobenzaprine Hcl | 150 | $995 |
| Methocarbamol | 38 | $477 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 90 | $388 |
| Methylprednisolone | 33 | $205 |
| Gabapentin | 28 | $150 |
| Meloxicam | 50 | $138 |
| Naproxen | 13 | $101 |
| Tizanidine Hcl | 18 | $86 |
| Ciprofloxacin Hcl | 25 | $69 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $44 |
| Tramadol Hcl | 20 | $39 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Memphis
- Kevin FoleyMemphis$162.4M
- Maurice SmithMemphis$4.4M
- Adam ArthurMemphis$1.9M
- Paul ParkMemphis$1.2M
- Daniel HoitMemphis$607K
- Jason GerrardMemphis$112K
- Earl JonesMemphis$59K
- Demi DawkinsMemphis$56K
- Isaac PomeraniecMemphis$56K
- Kyle SmithMemphis$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.